System And Process For Integrative Computational Soil Mapping

An integrative computational soil mapping system and process that reduces the required number of soil property measurements without jeopardizing the statistical precision of the resulting digital soil maps. The integrative computational soil mapping system and process saves monetary resources and time by reducing the number of soil property measurements required to produce digital soil maps and by offering soil sample locations which capture the maximum amount of representativeness of the soil characteristics in a determined area. In addition, the inventive system and process are integrative computational soil mapping that utilize algorithms based on state-of-the-art computational statistics and machine learning methods for the production of digital soil property maps and also provides soil sampling locations to collect new soil property measurements. These soil property measurements can be used to update and potentially improve previous versions of digital soil property maps, produced by the computational process

System And Process For Integrative Computational Soil Mapping

An integrative computational soil mapping system and process that reduces the required number of soil property measurements without jeopardizing the statistical precision of the resulting digital soil maps. The integrative computational soil mapping system and process saves monetary resources and time by reducing the number of soil property measurements required to produce digital soil maps and by offering soil sample locations which capture the maximum amount of representativeness of the soil characteristics in a determined area. In addition, the inventive system and process are integrative computational soil mapping that utilize algorithms based on state-of-the-art computational statistics and machine learning methods for the production of digital soil property maps and also provides soil sampling locations to collect new soil property measurements. These soil property measurements can be used to update and potentially improve previous versions of digital soil property maps, produced by the computational process

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

10.1161/CIRCULATIONAHA.119.042551CIRCULATION140191578-158

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Background After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1.4-1.8 mmol/L with ezetimibe or statins reduces cardiovascular events in patients with an acute coronary syndrome and diabetes. However, the efficacy and safety of further reduction in LDL cholesterol with an inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9) after acute coronary syndrome is unknown. We aimed to explore this issue in a prespecified analysis of the ODYSSEY OUTCOMES trial of the PCSK9 inhibitor alirocumab, assessing its effects on cardiovascular outcomes by baseline glycaemic status, while also assessing its effects on glycaemic measures including risk of new-onset diabetes